ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions
With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent
FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication
Industry Groups Lobby for Lower Standards for FDA Approval
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters - The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- CHMP recommends approval of Opdivo + Yervoy for unresectable or advanced HCC









